Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down
Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea. The post Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down appeared first on Investor's Business Daily.
Regeneron stock tumbled Tuesday after the biotech giant reported a major revenue miss due to light sales of its eye drug Eylea.
The post Regeneron Crashes 9% After Eylea Miss Drags Its Earnings Down appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
